(2010). A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis.
(2002). Agedependent spontaneous coronary arterial thrombosis in transgenic mice that express a stable form of human PAI-1.
(2002). Caveolae: from cell biology to animal physiology.
(2008). Caveolin-1 up-regulation during epithelial to mesenchymal transition is mediated by focal adhesion kinase.
(2006). Characterization of SIS3, a novel specific inhibitor of Smad3, and its effect on transforming growth factor-b1-induced extracellular matrix expression.
(2008). Cooperative Rho/ Rock and EGFR signaling in modulating TGF-b1-induced PAI-1 expression in vascular smooth muscle cells.
(2005). Critical role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis.
(1998). critical TGF-b-inducible elements in the promoter of human PAI-1 gene.
(2003). Distinct endocytic pathways regulate TGF-b receptor signaling and turnover.
(2009). Focal adhesion kinase: switching between GAPs and GEFs in the regulation of cell motility.
(2005). Heldin CH
(2010). Impairment of TGF-b signaling in caveolin-1 deficient hepatocytes: role in liver regeneration.
(2009). Integration of non-SMAD and SMAD signaling in TGF-b1-induced plasminogen activator inhibitor type-1 gene expression in vascular smooth muscle cells. Thromb Haemost 100: 976–
(2006). Integrin-regulated FAK-Src signaling in normal and cancer cells.
(2008). Lattices, rafts and scaffolds: domain regulation of receptor signaling at the plasma membrane.
(2010). Linking cell structure to gene regulation: signaling events and expression controls on the model genes PAI-1 and CTGF.
(2005). Loss of phosphatase and tensi homologue increases transforming growth factor bmediated invasion with enhanced SMAD3 transcriptional activity.
(2004). Molecular regulation of vascular smooth muscle cell differentiation in development and disease.
(2006). Multiple biomarkers for the prediction of first major cardiovascular events and death.
Nabi IR (2008) Caveolin-1 in tumor progression: The good, the bad and the ugly.
(2004). New insights into TGF-b-Smad signaling.
(2008). Opposite effects of dihydrosphingosine 1-phosphate and sphingosine 1-phosphate on transforming growth factor-b/Smad signaling are mediated through the PTEN/PPM1Adependent pathway.
(2010). Oxidative modification of nuclear mitogen-activated protein kinase phosphatase 1 is involved in transforming growth factor b1-induced expression of plasminogen activator inhibitor 1 in fibroblasts.
(2005). PAI-1 and atherothrombosis.
(2006). PAI-1 and TGF-b: unmasking the real driver of TGF-binduced vascular pathology.
(2001). PAI-1 deficiency prevents hypertension and vascular fibrosis in response to long-term nitric oxide synthase inhibition.
(2001). PAI-1 enhances neointima formation after oxidative vascular injury in atherosclerosis-prone mice.
(2001). PAI-1 increases neointima formation in balloon-injured rat carotid arteries.
(2005). Pharmacological inhibition and genetic deficiency of PAI-1 attenuates angiotensin II/salt-induced aortic remodeling.
(2006). Pivotal role of PAI-1 in a murine model of hepatic vein thrombosis.
(2005). Plasminogen activator inhibitor type-1 gene expression and induced migration in TGF-b1-stimulated smooth muscle cells is pp60c-src/MEK-dependent.
(2006). PPM1A functions as a Smad phosphatase to terminate TGF-b signaling.
(2005). Regulation of PTEN by Rho small GTPases.
(2004). Role of caveolae and caveolins in health and disease.
(2009). Signal transduction by focal adhesion kinase in cancer.
(2003). Smad-dependent and Smad-independent pathways in TGF-b family signaling.
(2010). Src redox regulation: again in the front line.
(2008). TGF-b-induced RhoA activation and fibronectin production in mesangial cells require caveolae.
(2006). TGF-b1 induces neointima formation through PAI-1 dependent pathways.